See also this year's filing and all EDGAR filings for this company.
PDF Report 0000792977_2020_AMAG_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000792977, AMAG Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 316,567,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 446,133,000 |
| 2 | PropertyPlantAndEquipmentNet | 4,116,000 |
| 3 | remainder_Assets | 24,411,000 |
| 4 | LiabilitiesCurrent | 208,194,000 |
| 5 | LiabilitiesNoncurrent | 19,880,000 |
| 6 | remainder_Liabilities | 277,034,000 |
| 7 | CostOfGoodsAndServicesSold | 107,193,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 286,182,528 |
| 9 | ResearchAndDevelopmentExpense | 67,524,272 |
| 10 | remainder_Expenses | 373,558,827 |
| 11 | remainder_Revenues | 314,343,158 |
| 12 | remainder_NetIncome | -19,622,644 |
| 13 | remainder_ComprehensiveNetIncome | 286,785 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 791,227,000 |
| 1 | Liabilities | 505,108,000 |
| 2 | Expenses | 834,458,627 |
| 3 | Revenues | 314,343,158 |
| 4 | StockholdersEquity | 286,119,000 |
| 5 | NetIncome | -539,738,113 |
| 6 | ComprehensiveNetIncome | -539,594,720 |
| 7 | BaseVar | 1,232,523,107 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.130 |
| 9 | EconomicCapitalRatio | 1.54 |
Edgar->Model Mapping
Feature Distribution
Change over Time
